Zim Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Zim Laboratories Ltd. on BSE

Load latest

Zim Laboratories Ltd.

15 Nov 2024

84.66

0.94%

Earnings Call

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, the transcript of Earnings Call for Q2 and H1 FY25 is attached herewith.

pdf

Zim Laboratories Ltd.

11 Nov 2024

84.66

0.94%

Earnings Call

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 read with with Schedule III of SEBI (LODR) Regulations 2015, the disclosure for audio recording of Q2 & H1 FY25 Earnings Conference Call is available on the Company''s website.

pdf

Zim Laboratories Ltd.

11 Nov 2024

84.66

0.94%

Company Update

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015 please find enclosed copies of newspaper publication regarding financial results for the quarter and half year ended 30.09.2024, published on 10.11.2024 in the newspapers.

pdf

Zim Laboratories Ltd.

09 Nov 2024

84.66

0.94%

Company Update

Zim Laboratories Ltd - 541400 - Q2 & H1 FY25 - Earnings Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (LODR) Regulation, 2015 Q2 and H1 FY25 - Earnings Presentation is enclosed herewith.

pdf

Zim Laboratories Ltd.

09 Nov 2024

84.66

0.94%

Result

Zim Laboratories Ltd - 541400 - Financial Results For The Quarter And Half Year Ended 30Th …

BSE India

Unaudited Financial Results for the Quarter and Half Year Ended 30th September, 2024 is enclosed herewith.

pdf

Zim Laboratories Ltd.

09 Nov 2024

84.66

0.94%

Company Update

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for Change in Senior Management Personnel is enclosed herewith.

pdf

Zim Laboratories Ltd.

09 Nov 2024

84.66

0.94%

Board Meeting

Zim Laboratories Ltd - 541400 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today have inter-alia considered and approved : 1. Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended 30th September, 2024. Copy of the Unaudited Financial Results (Consolidated and Standalone) along with the Limited Review Report issued by Walker Chandiok & Co LLP, Statutory Auditors of the Company is enclosed herewith. 2. Changes in the Senior Management of the Company : a. Categorization of Dr. Chandrashekhar Mainde, Technical Director as the Senior Management Personnel of the Company. b. Categorization of Dr. Uttam Kedar, Assistant Vice President - R&D as the Senior Management Personnel of the Company. The Board Meeting commenced at 03:00 p.m. and concluded at 06:15 p.m.

pdf

Zim Laboratories Ltd.

05 Nov 2024

84.66

0.94%

Company Update

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that Q2 & H1FY25 Earnings Conference Call is scheduled to be held on Monday, 11th November, 2024 at 12:00 p.m. (IST).

pdf

Zim Laboratories Ltd.

04 Nov 2024

84.66

0.94%

Board Meeting

Zim Laboratories Ltd - 541400 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI …

BSE India

Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors is scheduled to be held on Saturday, 09th November, 2024 to inter alia, consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2024. In connection with the above, as per SEBI (Prohibition of Insider Trading) Regulation, 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading by Insider's, the trading window for dealing with securities of the Company is closed from Tuesday the 01st October, 2024 to Monday, the 11th November, 2024 (both days inclusive).

pdf